Expect Trikafta to Bring Big Changes in Treating Cystic Fibrosis

October 2021

Trikafta (elexacaftor/tezacaftor/ivacaftor) will be a game changer for treating cystic fibrosis (CF).

This genetic disorder causes thick mucus to build up in the lungs and other parts of the body...leading to serious breathing problems and other complications.

Some of the important meds for treating the gene mutations that cause cystic fibrosis are Kalydeco, Orkambi, or Symdeko.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Influenza Take On a Bigger Role With Flu Vaccines in 2021-2022
COVID-19 Stay Alert for Ivermectin Rxs to Prevent or Treat COVID-19
COVID-19 Listen for Questions About Additional COVID-19 Vaccine Doses
Cystic Fibrosis Expect Trikafta to Bring Big Changes in Treating Cystic Fibrosis
Naloxone Listen for Questions About Higher Doses of Naloxone
Dosage Forms Reduce Errors With Orally Disintegrating Tablets
Allergic Reactions Keep Patients With Dye Allergies Safe
Med Safety Limit the Impact of Distractions and Interruptions
Pediatrics Help Reduce the Risk of Adrenal Problems in Kids Taking Steroids

Expect Trikafta to Bring Big Changes in Treating Cystic Fibrosis

Practical advice for a better career, with unlimited access to CE

Table of Contents